Navigation Links
Novartis Pharmaceuticals Corporation to Appeal Judgment in Alabama Pricing Case
Date:7/1/2008

Jury verdict in Montgomery County Circuit Court awards $33 million in

compensatory damages Jury decides in favor of Novartis and rejects claims for punitive damages NPC maintains it reported true and accurate prices and will file appeal

EAST HANOVER, N.J., July 1 /PRNewswire/ -- Novartis Pharmaceuticals Corporation (NPC) today announced it will appeal a verdict in the Montgomery County Circuit Court. Novartis disputes the State of Alabama's claims that the prices provided by NPC to reporting services resulted in overpayment to pharmacists and doctors in the Alabama State Medicaid system.

NPC was among 73 pharmaceutical manufacturers named in a lawsuit filed in 2005 by the Alabama Attorney General, claiming that the average wholesale price (AWP) and wholesale acquisition cost (WAC) provided by pharmaceutical companies to price reporting services resulted in overpayment to pharmacists and doctors in the State Medicaid system. The jury rejected the State's claims for punitive damages but decided against NPC on the State's claims for compensatory damages, awarding $33 million.

NPC believes Alabama's claims were unfounded because it reported true and accurate prices, based on terms that have been known and used by all participants in pharmaceuticals markets, including Alabama Medicaid, for more than 30 years.

Disclaimer

The foregoing release contains forward-looking statements that can be identified by terminology such as "to Appeal," "will," "believes," or similar expressions, or by express or implied discussions regarding the potential outcome of the forthcoming appeal in the litigation which is the subject of this press release, or of the potential outcome of any other pricing litigation. Such forward-looking statements reflect the current views of the Company regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results to be materia
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Novartis Vaccines Launches National Gift-Giving Program to Help Protect Loved Ones by Reserving an Influenza Vaccination
2. Colorado Influenza and Pneumococcal Alert Coalition (CIPAC) Partners with Novartis Vaccines for Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers
3. Novartis Vaccines Partners With RediClinic for Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers
4. Novartis Vaccines to Host Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers
5. Watson and Novartis Settle Lawsuit Over Exelon(R) Patent Litigation
6. Novartis and Sony Pictures Television Internationals Latin American Advertising Sales Group Launch Partnership to Create Multi-Media Platform for Breast Cancer Awareness, Detection, and Treatment in Latin America
7. Emerging Combination Therapies, Including Drugs from Novartis/Schering-Plough and GlaxoSmithKline/Theravance Will Drive the COPD Drug Market to More Than $11 Billion in 2017
8. Novartis, Pfizer and Merck Take the Lead on Strong Relationships with Physicians, as Doctors Demand an Expanding Set of Services
9. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
10. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
11. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2013)... CA (PRWEB) May 19, 2013 Passages ... addiction treatment center, has announced this week the launch ... through the brands’ social media channels. “We are ... addiction treatment community and to get feedback regarding sobriety, ... Prentiss, CEO and co-founder of the Passages Addiction ...
(Date:5/19/2013)... Minor fender benders and serious car accidents are common ... accident to respond appropriately to the situation. According ... from 2010, accidents, including car accidents, are the fifth ... 2005, automobile accident-related deaths cost over $70 ... drivers and passengers receive treatment in an emergency room ...
(Date:5/18/2013)... Daily Gossip issued a press release last ... their page. John Colston, Daily Gossip’s spokesperson, told the press ... 14-Day Rapid Fat Loss Plan . , Shaun ... healthy at a time when nutritionists and fat loss gurus ... , The diet is based on the Macro-Patterning ...
(Date:5/18/2013)... California (PRWEB) May 18, 2013 Online watch ... be Rolex watch owners at a fraction of ... of luxury timepieces in the world, buyers are urged to ... compared to buying a Rolex watch from a brick-and-mortar store, ... owned Rolex watches priced at unbelievable rates. Although some ...
(Date:5/18/2013)... an original art book for iPad with tango as its ... share their creations based on the traditional music genre through ... . , This work gathers more than 150 original ... idiosyncrasy and passion of tango. Such book is available ... includes a free trailer of the book for readers to ...
Breaking Medicine News(10 mins):Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 2Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 3Health News:Auto Accident Infographic Issued by d’Oliveira & Associates on Steps to Take After a Car Crash 2Health News:Time and Gems Offers Buyers the Largest Collection of Rolex Watches Yet 2Health News:Time and Gems Offers Buyers the Largest Collection of Rolex Watches Yet 3Health News:New Art Book for iPad: Tango Art 2
... TAMPA, Fla., July 23 Bay Area Registered ... drugs and armed himself with a movie to help save ... illness, Burton found an alarming connection between America,s food ingredients ... he,s going to tell the world what he found. The ...
... over recent years. This is fact, but what is not ... centres have shown that family conflict is not a significant ... are striking: in Spain, 24% of women take antidepressants and ... psychopharmaceuticals is often related to family or work-related problems. We ...
... , BATESVILLE, Ind., July 23 Hill-Rom ... release will be issued Thursday, August 6, 2009. You are invited ... at 8 a.m. EDT. , Earnings Release: ... June 30, 2009 will be released to the public after the NYSE ...
... , , NEW YORK, July 23 ... UNICEF,s Next Generation to engage young adults with UNICEF,s mission to ... UNICEF,s Next Generation steering committee is dedicated to reducing the number ... Jenna Bush Hager, a longtime supporter of UNICEF, will lead the ...
... ANAHEIM, Calif., July 23 At the 2009 American ... 26-30 in Anaheim, California, Elekta will demonstrate how the company,s comprehensive ... deliver superior cancer care with precision and ease. , ... plan and deliver radiation treatments, Elekta booth 423 will highlight ...
... , WARREN, N.J., July 23 ... company specializing in dissolving thin film pharmaceutical products, today announced the ... Mr. Clemente will report to Keith J. Kendall, Executive Vice ... Kendall stated, "We are pleased to welcome Ted to MonoSol Rx ...
Cached Medicine News:Health News:Nurse Turned Filmmaker Makes Lifesaving Film 2Health News:Almost 1 quarter of Spanish women take antidepressants 2Health News:Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2009 Third Quarter Earnings Webcast 2Health News:U.S. Fund for UNICEF and Jenna Bush Hager Announce Next Generation Initiative to Improve Lives of Children Around the World 2Health News:Comprehensive VMAT Solution From Elekta on Center Stage at 2009 AAPM Annual Meeting 2Health News:Comprehensive VMAT Solution From Elekta on Center Stage at 2009 AAPM Annual Meeting 3Health News:MonoSol Rx Appoints Theodore Clemente Vice President Business Development 2Health News:MonoSol Rx Appoints Theodore Clemente Vice President Business Development 3
(Date:5/17/2013)... 2013  Sanofi (EURONEXT: SAN and NYSE: SNY ... JAKARTA , examining the selective JAK2 inhibitor SAR302503 ... dose groups. The primary endpoint assessed the proportion of ... data reported in previous trials, the most common adverse ... will be presented at an upcoming medical congress. ...
(Date:5/16/2013)... ZURICH , May 17, 2013 ... Research (A*STAR) and Switzerland,s Cytos Biotechnology ... dosed in a Phase 1 clinical trial with their H1N1 ... particle (VLP) technology. In this first Phase 1 clinical trial, ... its potential to protect against H1N1 influenza infection will be ...
(Date:5/16/2013)... -- Today, the National Patient Advocate Foundation acknowledges that the ... recently approved a bill that would prohibit insurers who ... fees for newer, more expensive oral anti-cancer drugs than ... side-effects. However, the bill was amended to include a ... be a barrier to patients with cancer and in ...
Breaking Medicine Technology:Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 2National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 3
... Sparta Systems, Inc., the maker of TrackWise® software ... compliance solutions, today announced that Ascent Healthcare Solutions, ... has selected its TrackWise Enterprise Quality Management System ... compliance with industry regulations. Ascent will deploy ...
... Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD ) announced ... with the U.S. Food and Drug Administration (FDA) regarding ... series of measures that, when satisfied, will permit Caraco ... manufactured in its Detroit area facilities. The Company is ...
Cached Medicine Technology:Leading Medical Device Provider Chooses TrackWise(R) Software to Optimize Customer Complaint Handling 2Leading Medical Device Provider Chooses TrackWise(R) Software to Optimize Customer Complaint Handling 3Caraco Pharmaceutical Laboratories, Ltd. Enters Into Consent Decree with FDA Providing Path to Resume Manufacturing Operations 2
Straight shaft; a 5mm platform with 0.3mm 1x2 teeth; In Titanium....
Fine .12mm Tip With 5mm Platform; In Titanium....
Curved 30mm shaft (in stainless steel); rubber coated for safer use; includes 1.5 meter cable and connectors....
Straight shafts with extra fine pointed tips and 6mm tying platform. Smooth handle with dull finish/...
Medicine Products: